Format

Send to

Choose Destination
J Fla Med Assoc. 1992 Dec;79(12):821-2.

Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.

Author information

1
Department of Internal Medicine, University of South Florida College of Medicine, Tampa.

Abstract

A case is reported of reversible sensorineural hearing loss associated with intravenous erythromycin treatment. Cis-platinum induced high frequency hearing loss developed nine months previously during treatment for stage IV papillary cystadenocarcinoma. Renal and hepatic function were normal; however, serum erythromycin levels were elevated. Clinical recovery promptly followed discontinuation of erythromycin.

PMID:
1474367
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center